Show Stocks and Investing Publications • Thu, August 8, 2024
Andrew Fein Reiterated (ACAD) at Strong Buy and Held Target at $27 on, Aug 8th, 2024
ein-reiterated-acad-at-strong-buy-and-held-target-at-27-on-aug-8th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIAndrew Fein of HC Wainwright & Co., Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $27 on, Aug 8th, 2024.
Andrew has made no other calls on ACAD in the last 4 months.
There are 10 other peers that have a rating on ACAD. Out of the 10 peers that are also analyzing ACAD, 5 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $20 on, Wednesday, August 7th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $22 on, Friday, May 10th, 2024
- Uy Ear of "Mizuho" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Jay Olson of "Oppenheimer" Maintained at Hold and Held Target at $19 on, Monday, May 6th, 2024
These are the ratings of the 5 analyists that currently disagree with Andrew
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $28 on, Wednesday, August 7th, 2024
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $28 on, Wednesday, August 7th, 2024
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $26 on, Wednesday, August 7th, 2024
- Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $31 on, Thursday, June 27th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Thursday, May 9th, 2024
Like: 👍